No CrossRef data available.
Article contents
Molecular characterization of a suspected IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreak reveals two simultaneous outbreaks in a tertiary-care hospital
Published online by Cambridge University Press: 04 May 2023
Abstract
Objective:
To describe IMP-type carbapenemase-producing Pseudomonas aeruginosa outbreaks at Galdakao University Hospital between March 2021 to December 2021.
Design:
Outbreak report.
Setting:
Galdakao University Hospital is a tertiary-care hospital in the Basque Country (northern Spain).
Patients:
All patients with a positive IMP-type carbapenemase producing Pseudomonas aeruginosa (IMP-PA) culture were included in this study, both colonization and infection cases.
Methods:
An outbreak investigation was conducted, in which molecular epidemiology analysis [pulsed-field gel electrophoresis and whole-genome sequencing (WGS)] and environmental screenings were performed.
Results:
Between March and December 2021, 21 cases of IMP-PA were detected in Galdakao University Hospital: 18 infection cases and 3 colonization cases. In total, 4 different pulsotypes were detected belonging to 4 clones according to WGS: ST175 (n = 14), ST633 (n = 3), ST179 (n = 3), and ST348 (n = 1). IMP-13 was detected in most isolates belonging to the ST175 clone and in all ST179 and ST348 clones, whereas IMP-29 was detected in isolates belonging to the ST633 clone. Clinical isolates belonging to the ST175 clone were isolated mainly from patients admitted to the respiratory ward, and isolates belonging to the ST633 clone from patients admitted to the ICU. Two environmental isolates belonging to the ST175 clone were detected in the respiratory ward.
Conclusions:
Molecular and genomic epidemiology revealed that there had been 2 independent IMP-PA outbreaks, one of long duration in the respiratory ward and the other more limited in the ICU.
- Type
- Original Article
- Information
- Copyright
- © The Author(s), 2023. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Footnotes
a
Both authors contributed equal.
References
del Barrio-Tofiño, E, López-Causapé, C, Oliver, A.
Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update. Int J Antimicrob Agents 2020;56.Google ScholarPubMed
Fernández-Cuenca, F, López-Cerero, L, Cabot, G, et al. Nosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa
. Eur J Clin Microbiol Infect Dis 2020;39:1837–1844.CrossRefGoogle ScholarPubMed
del Barrio-Tofiño, E, López-Causapé, C, Cabot, G, et al. Genomics and susceptibility profiles of extensively drug-resistant Pseudomonas aeruginosa isolates from Spain. Antimicrob Agents Chemother 2017;61:1–13.CrossRefGoogle ScholarPubMed
del Barrio-Tofi, E, Zamorano, L, Cortes-Lara, S, et al. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.Google Scholar
Baiou, A, Elbuzidi, AA, Bakdach, D, et al. Clinical characteristics and risk factors for the isolation of multidrug-resistant gram-negative bacteria from critically ill patients with COVID-19. J Hosp Infect 2021;110:165–171.CrossRefGoogle Scholar
Aliberti, S, Cilloniz, C, Chalmers, JD, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax 2013;68:997–999.CrossRefGoogle ScholarPubMed
Ansari, S, Hays, JP, Kemp, A, et al. The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR insights global perspective. JAC-Antimicrobial Resist 2021;3.Google ScholarPubMed
European Committee on Antimicrobial Susceptibility Testing (EUCAST). European Committee on Antimicrobial Susceptibility Testing breakpoint tables for interpretation of MICs and zone diameters, version 11.0. EUCAST website. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf. Published 2021.Google Scholar
Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.CrossRefGoogle ScholarPubMed
López-Causapé, C, Mette Sommer, L, Cabot, G, et al. Evolution of the Pseudomonas aeruginosa mutational resistome in an international cystic fibrosis clone. Sci Rep 2017;7:5555.CrossRefGoogle Scholar
Cortes-Lara, S, Barrio-Tofiño, E del, López-Causapé, C, et al. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole-genome sequence resistome analysis. Clin Microbiol Infect 2021;27:1631–1637.CrossRefGoogle ScholarPubMed
Tacconelli, E, Cataldo, MA, Dancer, SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 2014;20 suppl 1:1–55.CrossRefGoogle Scholar
Rossi, E, La Rosa, R, Bartell, JA, et al.
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis. Nat Rev Microbiol 2021;19:331–342.CrossRefGoogle ScholarPubMed
Kanamori, H, Weber, DJ, Rutala, WA. Healthcare outbreaks associated with a water reservoir and infection prevention strategies. Clin Infect Dis 2016;62:1423–1435.CrossRefGoogle ScholarPubMed
Kizny Gordon, AE, Mathers, AJ, Cheong, EYL, et al. The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections—a systematic review of the literature. Clin Infect Dis 2017;64:1436–1444.CrossRefGoogle ScholarPubMed